Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.5360
-0.0140 (-2.55%)
Last updated: Mar 13, 2026, 1:15 PM CET

EPA:ALOPM Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22
10133012
Market Cap Growth
37.31%-56.74%155.14%-
Enterprise Value
141123-
Last Close Price
0.530.711.811.70
PS Ratio
5.527.9317.241.42
PB Ratio
0.92-30.218.131.00
P/TBV Ratio
1.03-11.791.07
EV/Sales Ratio
7.877.0113.18-
Debt / Equity Ratio
0.63-17.652.390.22
Net Debt / Equity Ratio
0.39-5.37-0.41-0.91
Net Debt / EBITDA Ratio
0.63-0.310.167.45
Asset Turnover
-0.120.10-
Quick Ratio
1.942.393.454.10
Current Ratio
7.512.533.534.14
Return on Equity (ROE)
--442.13%-104.58%-
Return on Assets (ROA)
--35.69%-35.51%-
Return on Capital Employed (ROCE)
35.90%-107.20%-79.20%-11.20%
Earnings Yield
65.30%-55.58%-26.98%-1.97%
Buyback Yield / Dilution
--9.16%0.48%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.